About us
Welcome to the newest virtual home of the Philadelphia Area Java Users’ Group, twice rated by Sun as one of the world’s top Java User Groups! The Philly JUG’s main objective is to provide great learning events for our membership, and if you look at our history we’ve done just that. Over the past fifteen+ years the Philly JUG has done quite a bit of growing up. Very few of you might remember our first meeting, where about 35 members sat on the floor in the office of a long departed dot com. If you have been to a meeting recently you know how far we have come.
Current Philly JugMaster: Greg Taylor.
Upcoming events
1
Not Another RAG Talk: Building AI Chatbots in Java with Spring AI
Certara, 4 Radnor Corporate Center, Suite 350, 100 Matsonford Road, Radnor, PA, USLarge language models can do more than answer questions, they can take actions. This talk walks through building a chatbot for an internal business app using Java 25 and Spring AI, where the LLM queries databases, performs write operations, and enforces role-based permissions.
We'll cover an agentic loop that gives the application control over each LLM round-trip, "defense in depth" database access, a propose/confirm pattern for write operations, and more (role-based tool visibility, a cheap relevancy gate for off-topic screening, and a sub-agent pattern for context-aware UI navigation help).
About the Speaker
Sujan Kapadia
Sujan Kapadia is the Chief AI Officer at Chariot Solutions, where he leads the company’s AI strategy and execution. Sujan is a practitioner and leader with over 25 years of experience shipping complex systems. He focuses on the practical applications of AI and agents, believing real AI transformation is earned through visible wins, not promises on a roadmap. Companies already have the signal they need, but it gets lost in the noise. Helping them find and use it is the part Sujan loves most.About the Sponsor
Certara (https://www.certara.com)
Certara accelerates medicines to patients, using biosimulation (modeling and simulation) and technology-enabled services to transform drug discovery and development. Our integrated and proprietary end-to-end platform with generative AI technology, biosimulation, regulatory science, and market access solutions combined with our global 1,400+ strong team of scientists and experts enable informed decision-making, higher R&D productivity, and improved patient outcomes.27 attendees
Past events
121
Group links
Organizers
Members
3,264
